Science Explorer Back to mapMap
Discussion
Topic · Microbiology

Actinomycetales infections and treatment

Actinomycetales infections and treatment is a research topic within Microbiology. Science Explorer counts 7.8k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the clinical and molecular aspects of Nocardiosis, including Nocardia spp., actinomycosis, mycetoma, antimicrobial susceptibility, transplant recipients, genomic sequencing, taxonomy, epidemiology, and clinical features. It provides insights into the risk factors, characteristics, outcomes, and management of Nocardia infections in various patient populations.

  • Nocardia spp.
  • Actinomycosis
  • Mycetoma
  • Antimicrobial Susceptibility
  • Transplant Recipients
  • Genomic Sequencing
  • Taxonomy
  • Epidemiology
  • Clinical Features
  • Diagnosis
Research works
7.8k
fractional, since 1950
In the world top 10%
784
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+20%
the tick is no change
Largest producer
United States
32% of the 10 largest, 2022-now
Actinomycetales infections and treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Actinomycetales infections and treatment research?

By volume, the United States and China publish the most (306 and 191 works in 2022-now).

By volume, 2022-now

  1. 1 United States 306 works
  2. 2 China 191 works
  3. 3 India 166 works
  4. 4 Japan 85 works
  5. 5 Brazil 48 works
  6. 6 Spain 40 works
  7. 7 United Kingdom 38 works
  8. 8 Germany 32 works
  9. 9 Italy 31 works
  10. 10 France 31 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.6%China: 19.7%India: 17.2%Japan: 8.8%6 others listed: 22.8%32%largest
United States306 · 31.6%China191 · 19.7%India166 · 17.2%Japan85 · 8.8%6 others listed220 · 22.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Actinomycetales infections and treatment research?

By volume in 2022-now, Mayo Clinic publishes the most Actinomycetales infections and treatment research, followed by All India Institute of Medical Sciences and University of Khartoum.

Who are the leading researchers in Actinomycetales infections and treatment?

The most-cited researchers publishing on Actinomycetales infections and treatment include Jun Wang, Patrizio Lancellotti and Didier Raoult.

  1. 1 Jun Wang China 340k citations
  2. 2 Patrizio Lancellotti Belgium 245k citations
  3. 3 Didier Raoult France 232k citations
  4. 4 Ziad Ahmed Memish Saudi Arabia 224k citations
  5. 5 Bernard Iung France 203k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Actinomycetales infections and treatment?

The most cited paper in Actinomycetales infections and treatment is "Methods for characterization of Streptomyces species" (E. B. SHIRLING, David J. Gottlieb, 1966), with 5,791 citations. Next come "Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)" (3,297) and "Proposed minimal standards for the use of genome data for the taxonomy of prokaryotes" (3,167).

Most cited papers
#PaperReleasedCitations
1 Methods for characterization of Streptomyces species E. B. SHIRLING, David J. Gottlieb · International Journal of Systematic Bacteriology Jul 1966 5,791
2 Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) Stephen D. Bentley et al. · Nature May 2002 3,297
3 Proposed minimal standards for the use of genome data for the taxonomy of prokaryotes Jongsik Chun, Aharon Oren, António Ventosa et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY Open access 2018 3,167
4 List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ Aidan C. Parte, J. Sarda Carbasse, Jan P. Meier‐Kolthoff et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY Open access 23 Jul 2020 2,045
5 Proposal for a New Hierarchic Classification System, Actinobacteria classis nov. Erko Stackebrandt, F. A. RAINEY, Naomi L. Ward-Rainey · International Journal of Systematic Bacteriology Apr 1997 1,731
All 99 most cited papers, with filters and sorting

Where is Actinomycetales infections and treatment research done?

The largest centres of Actinomycetales infections and treatment research in 2022-now are Beijing (China), Tokyo (Japan), Khartoum (Sudan) and New Delhi (India).

Largest cities, 2022-now

  1. 1 BeijingChina 28 works
  2. 2 TokyoJapan 20 works
  3. 3 KhartoumSudan 18 works
  4. 4 New DelhiIndia 18 works
  5. 5 Mexico CityMexico 14 works
  6. 6 GuangzhouChina 14 works
  7. 7 São PauloBrazil 14 works
  8. 8 HangzhouChina 13 works
  9. 9 ChennaiIndia 13 works
  10. 10 ParisFrance 11 works
See Actinomycetales infections and treatment on the map

Where is the best place to study Actinomycetales infections and treatment?

Among universities, judged by research, University of Khartoum and All India Institute of Medical Sciences score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of KhartoumSudan 55.021.2%167.1×13 +0.2%
2All India Institute of Medical SciencesIndia 39.53.3%13.2×18 +18.0%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Actinomycetales infections and treatment, country by country

Is Actinomycetales infections and treatment research growing?

Output in 2022-2025 was 20% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Actinomycetales infections and treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Actinomycetales infections and treatment as a percentage of every work published that year, 0.0060% in 2024.

still counting0.0050%0.010%0.015%Actinomycetales infections and treatment0.0057% in 202519801990200020102020

Fractional works of Actinomycetales infections and treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Actinomycetales infections and treatment10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Actinomycetales infections and treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.